These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7634918

  • 21. Initiating levodopa therapy for Parkinson's disease.
    Olanow CW, Kieburtz K, Stocchi F.
    Mov Disord; 2014 Mar; 29(3):430. PubMed ID: 24408661
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Paradoxal neurological side-effects of neuroleptics. Classification and occurrence].
    Korsgaard S, Gerlach J, Noring U, Povlsen UJ.
    Ugeskr Laeger; 1987 Jun 15; 149(25):1685-8. PubMed ID: 2885955
    [No Abstract] [Full Text] [Related]

  • 25. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E.
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov 15; 11(6):294-8. PubMed ID: 33397
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Buccofacial dyskinesia of iatrogenic origin].
    Reynes P, Guichard M, Guiraud P.
    Rev Odontostomatol (Paris); 1983 Nov 15; 12(6):461-9. PubMed ID: 6142519
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Screening for tardive dyskinesia.
    Munetz MR, Schulz SC.
    J Clin Psychiatry; 1986 Feb 15; 47(2):75-7. PubMed ID: 2867994
    [Abstract] [Full Text] [Related]

  • 31. Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.
    Kim JM, Lee KH, Choi YL, Choe GY, Jeon BS.
    Mov Disord; 2002 Sep 15; 17(5):1089-90. PubMed ID: 12360566
    [Abstract] [Full Text] [Related]

  • 32. Rating scales for dyskinesias in Parkinson's disease.
    Goetz CG.
    Mov Disord; 1999 Sep 15; 14 Suppl 1():48-53. PubMed ID: 10493403
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prevention and management of tardive dyskinesia.
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1985 Apr 15; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM.
    J Am Geriatr Soc; 2004 Dec 15; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.